Juno Therapeutics
Fully-Leased Single Tenant Office Building in Seattle’s Belltown Neighborhood Hits the Market
By Meghan Hall A single-tenant office asset at the heart of Seattle’s Belltown neighborhood has been posted for sale, offering investors a stable...
Kinzer Partners Complete Sale of 601 Dexter in Seattle for $28.5MM
SEATTLE, WA – Kinzer Partners’ Capital Markets team today announced the sale of 601 Dexter Avenue North in Seattle on behalf of Base...
Alexandria Expands Its Seattle Life Science Campuses, Announces Delivery of 300,000 SQFT by 2Q19
PASADENA, Calif., (February 7, 2019) — Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology...
BioMed Realty Sells Life Science Building in Bothell for $18.15MM
By Brittan Jenkins Nevada-based Jump Holdings LLC is the new owner of a life science building located in the Canyon Park life science...
Seattle-Bellevue Life Sciences Industry Major Contributor to State GDP
By Jacob Bourne The life sciences industry, including biotech and pharmaceuticals, made significant strides in 2015, totaling $520 billion in mergers and acquisitions...
Skanska Signs $43MM Contract for Tenant Improvements with Juno Therapeutics in Seattle’s South Lake Union
Skanska, one of the world’s leading construction and development firms, announced it has signed a $43 million contract with Juno Therapeutics to complete...
Alexandria Adds to Exposure in South Lake Union With Land Purchase and New Development
By Jon Peterson Pasadena, Calif.-based Alexandria Real Estate Equities is expanding its office building presence in the South Lake Union sub-market of Seattle...
